Last edition
News about "Saharsh Davuluri"
Neuland Accelerates Peptide Manufacturing Expansion
Neuland expands peptide manufacturing capacity as its first commercial peptide module becomes operational, with further expansion underway to meet rising customer demand.
Saharsh Davuluri | 15/09/2026 | By News Bureau
Gland Pharma and Neuland Partner for Sterile API Manufacturing
Gland Pharma and Neuland Laboratories have partnered to expand sterile Active Pharmaceutical Ingredient (API) manufacturing through a new state-of-the-art current Good Manufacturing Practice (GMP) sterile manufacturing suite.
Saharsh Davuluri | 06/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy